Literature DB >> 7662245

Relative androgenicity, blood pressure levels, and cardiovascular risk factors in young healthy women.

C S Mantzoros1, E I Georgiadis, R Young, C Evagelopoulou, S Khoury, N Katsilambros, J R Sowers.   

Abstract

To test the hypothesis that androgens may play a role in the pathogenesis of atherosclerosis and hypertension, we investigated the association of delta 5 dehydroepiandrosterone sulfate [DHEAS]) and delta 4 (free testosterone [FT]) androgens with the resting, seated blood pressure (BP) levels and cardiovascular risk factors in 280 young, healthy women 18 to 24 years of age. After application of multiple regression analysis, systolic BP was positively and independently correlated with the ratio of dehydroepiandrosterone sulfate to free testosterone (DHEAS/FT), fasting insulin levels, and the diastolic BP with DHEAS/FT only. The DHEAS/FT ratio proved to be a stronger predictor of the BP levels than either hormone alone. Further, uric acid concentrations and HDL/total cholesterol ratio were independently correlated with both FT and body mass index in these young women. Serum triglycerides were independently correlated with FT and central body fat distribution. These data suggest that serum androgen concentrations are important independent predictors of cardiovascular risk factors and that the ratio of dehydroepiandrosterone sulfate to free testosterone ratio is an independent predictor of blood pressure levels in young women.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7662245     DOI: 10.1016/0895-7061(95)00051-P

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  11 in total

1.  Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.

Authors:  V R Holla; F Adas; J D Imig; X Zhao; E Price; N Olsen; W J Kovacs; M A Magnuson; D S Keeney; M D Breyer; J R Falck; M R Waterman; J H Capdevila
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 2.  Pre-analytic considerations for the proper assessment of hormones of the hypothalamic-pituitary axis in epidemiological research.

Authors:  Rachel L Derr; Scott J Cameron; Sherita Hill Golden
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

3.  Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.

Authors:  Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green
Journal:  Vasc Med       Date:  2017-01-17       Impact factor: 3.239

4.  Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the women's interagency HIV study (WIHS).

Authors:  Roksana Karim; Wendy J Mack; Naoko Kono; Phyllis C Tien; Kathryn Anastos; Jason Lazar; Mary Young; Mardge Cohen; Elizabeth Golub; Ruth M Greenblatt; Robert C Kaplan; Howard N Hodis
Journal:  J Clin Endocrinol Metab       Date:  2013-02-15       Impact factor: 5.958

5.  Preeclampsia and androgen receptor gene CAG repeat length: results from both children and women.

Authors:  Tanja Saarela; Jarmo Jääskeläinen; Sirpa Tenhola; Raimo Voutilainen; Seppo Heinonen
Journal:  J Assist Reprod Genet       Date:  2005-08       Impact factor: 3.412

6.  Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.

Authors:  U Durmus; C Duran; S Ecirli
Journal:  J Endocrinol Invest       Date:  2016-11-12       Impact factor: 4.256

Review 7.  Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Mimi S Kim; Deborah P Merke
Journal:  Semin Reprod Med       Date:  2009-06-15       Impact factor: 1.303

8.  Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.

Authors:  Roksana Karim; Howard N Hodis; Frank Z Stanczyk; Rogerio A Lobo; Wendy J Mack
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

Review 9.  Menstrual health and the metabolic syndrome in adolescents.

Authors:  Hala Tfayli; Silva Arslanian
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

10.  Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome.

Authors:  Liangshan Mu; Jiexue Pan; Lili Yang; Qianqian Chen; Ya Chen; Yili Teng; Peiyu Wang; Rong Tang; Xuefeng Huang; Xia Chen; Haiyan Yang
Journal:  Reprod Biol Endocrinol       Date:  2018-10-25       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.